Trial Details

Not Recruiting
Basic Information
Clinical ID c5485
Identifier ACTRN12616000602426
Trial Title Thioguanine Suppositories For Proctitis. An Open Label Phase I Study To Evaluate the Efficacy and Safety of TG as a suppository
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions inflammatory bowel disease (IBD);proctitis; inflammatory bowel disease (IBD) proctitis;Oral and Gastrointestinal - Inflammatory bowel disease
Interventions The overall aim of the current study is to evaluate the safety and efficacy of low dose thioguanine 20mg suppositories in an open-label phase I study involving up to 10 patients with severe proctitis, who are unresponsive to the current standard of care t
Participant Information
Sponsor Mater Hospital Brisbane
City NULL
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase PHASE1
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL